Cargando…
Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
Nitric oxide synthase 3 (NOS3) catalyzes production of NO in the endothelium and may play a role in cardiovascular disease (CVD). We assessed the pharmacogenetic associations of three NOS3 polymorphisms and three antihypertensive drugs with CVD outcomes. Hypertensive subjects (n = 30,280) from a mul...
Autores principales: | Zhang, Xue, Lynch, Amy I., Davis, Barry R., Ford, Charles E., Boerwinkle, Eric, Eckfeldt, John H., Leiendecker-Foster, Catherine, Arnett, Donna K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314599/ https://www.ncbi.nlm.nih.gov/pubmed/22470539 http://dx.doi.org/10.1371/journal.pone.0034217 |
Ejemplares similares
-
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT
por: Lynch, Amy I., et al.
Publicado: (2013) -
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
por: Do, Anh N., et al.
Publicado: (2014) -
The effects of genes implicated in cardiovascular disease on blood-pressure response to treatment among treatment-naïve hypertensive African Americans in the GenHAT study
por: Do, Anh N, et al.
Publicado: (2016) -
Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension
por: Tanner, Rikki M., et al.
Publicado: (2011) -
Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
por: Armstrong, Nicole D., et al.
Publicado: (2022)